These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33287829)

  • 1. Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance.
    Martini N; Aimo A; Barison A; Della Latta D; Vergaro G; Aquaro GD; Ripoli A; Emdin M; Chiappino D
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):84. PubMed ID: 33287829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
    Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
    Baggiano A; Boldrini M; Martinez-Naharro A; Kotecha T; Petrie A; Rezk T; Gritti M; Quarta C; Knight DS; Wechalekar AD; Lachmann HJ; Perlini S; Pontone G; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):69-80. PubMed ID: 31202744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis.
    Boldrini M; Cappelli F; Chacko L; Restrepo-Cordoba MA; Lopez-Sainz A; Giannoni A; Aimo A; Baggiano A; Martinez-Naharro A; Whelan C; Quarta C; Passino C; Castiglione V; Chubuchnyi V; Spini V; Taddei C; Vergaro G; Petrie A; Ruiz-Guerrero L; Moñivas V; Mingo-Santos S; Mirelis JG; Dominguez F; Gonzalez-Lopez E; Perlini S; Pontone G; Gillmore J; Hawkins PN; Garcia-Pavia P; Emdin M; Fontana M
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):909-920. PubMed ID: 31864973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
    Khalique Z; Ferreira PF; Scott AD; Nielles-Vallespin S; Martinez-Naharro A; Fontana M; Hawkins P; Firmin DN; Pennell DJ
    Circ Cardiovasc Imaging; 2020 May; 13(5):e009901. PubMed ID: 32408830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis.
    Pan JA; Kerwin MJ; Salerno M
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1299-1310. PubMed ID: 32498919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.
    Ridouani F; Damy T; Tacher V; Derbel H; Legou F; Sifaoui I; Audureau E; Bodez D; Rahmouni A; Deux JF
    J Cardiovasc Magn Reson; 2018 Aug; 20(1):58. PubMed ID: 30115079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
    Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
    Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis.
    Dohy Z; Szabo L; Pozsonyi Z; Csecs I; Toth A; Suhai FI; Czimbalmos C; Szucs A; Kiss AR; Becker D; Merkely B; Vago H
    PLoS One; 2022; 17(6):e0269807. PubMed ID: 35696411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality assurance of late gadolinium enhancement cardiac magnetic resonance images: a deep learning classifier for confidence in the presence or absence of abnormality with potential to prompt real-time image optimization.
    Zaman S; Vimalesvaran K; Chappell D; Varela M; Peters NS; Shiwani H; Knott KD; Davies RH; Moon JC; Bharath AA; Linton NW; Francis DP; Cole GD; Howard JP
    J Cardiovasc Magn Reson; 2024; 26(1):101040. PubMed ID: 38522522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.
    Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A
    Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
    Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
    Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M; Ćorović A; Scully P; Moon JC
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Replacing Late Gadolinium Enhancement With Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy.
    Zhang Q; Burrage MK; Lukaschuk E; Shanmuganathan M; Popescu IA; Nikolaidou C; Mills R; Werys K; Hann E; Barutcu A; Polat SD; ; Salerno M; Jerosch-Herold M; Kwong RY; Watkins HC; Kramer CM; Neubauer S; Ferreira VM; Piechnik SK
    Circulation; 2021 Aug; 144(8):589-599. PubMed ID: 34229451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease.
    Rausch K; Scalia GM; Sato K; Edwards N; Lam AK; Platts DG; Chan J
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):81-90. PubMed ID: 32728989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left and right ventricular strain using fast strain-encoded cardiovascular magnetic resonance for the diagnostic classification of patients with chronic non-ischemic heart failure due to dilated, hypertrophic cardiomyopathy or cardiac amyloidosis.
    Steen H; Giusca S; Montenbruck M; Patel AR; Pieske B; Florian A; Erley J; Kelle S; Korosoglou G
    J Cardiovasc Magn Reson; 2021 Apr; 23(1):45. PubMed ID: 33823860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.
    Pöyhönen P; Hiippala A; Ollila L; Kaasalainen T; Hänninen H; Heliö T; Tallila J; Vasilescu C; Kivistö S; Ojala T; Holmström M
    J Cardiovasc Magn Reson; 2015 Oct; 17():89. PubMed ID: 26496977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delay enhancement patterns in apical hypertrophic cardiomyopathy by phase-sensitive inversion recovery sequence.
    Guo ZY; Chen J; Liang QZ; Liao HY; Fu SX; Tang QY; Chen CX; Han XJ; Gao F
    Asian Pac J Trop Med; 2012 Oct; 5(10):828-30. PubMed ID: 23043925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy.
    Lavall D; Vosshage NH; Geßner R; Stöbe S; Ebel S; Denecke T; Hagendorff A; Laufs U
    Clin Res Cardiol; 2023 Mar; 112(3):334-342. PubMed ID: 35355115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.